11-981270-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_012305.4(AP2A2):c.676G>A(p.Val226Met) variant causes a missense change. The variant allele was found at a frequency of 0.00000744 in 1,613,318 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000013 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0000068 ( 0 hom. )
Consequence
AP2A2
NM_012305.4 missense
NM_012305.4 missense
Scores
3
9
7
Clinical Significance
Conservation
PhyloP100: 6.73
Genes affected
AP2A2 (HGNC:562): (adaptor related protein complex 2 subunit alpha 2) The protein encoded by this gene is a subunit of the AP-2 adaptor protein complex, which is involved in linking lipid and protein membrane components with the clathrin lattice. This interaction supports the formation of clathrin-coated vesicles, and the encoded subunit aids in the process by binding polyphosphoinositide-containing lipids in the cell membrane. [provided by RefSeq, Nov 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BS2
High AC in GnomAdExome4 at 10 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AP2A2 | NM_012305.4 | c.676G>A | p.Val226Met | missense_variant | 6/22 | ENST00000448903.7 | NP_036437.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AP2A2 | ENST00000448903.7 | c.676G>A | p.Val226Met | missense_variant | 6/22 | 1 | NM_012305.4 | ENSP00000413234.3 | ||
AP2A2 | ENST00000332231.9 | c.676G>A | p.Val226Met | missense_variant | 6/22 | 1 | ENSP00000327694.5 | |||
AP2A2 | ENST00000528815.5 | n.676G>A | non_coding_transcript_exon_variant | 6/21 | 2 | ENSP00000431630.1 | ||||
AP2A2 | ENST00000687792.1 | n.676G>A | non_coding_transcript_exon_variant | 6/21 | ENSP00000508951.1 | |||||
AP2A2 | ENST00000687890.1 | n.676G>A | non_coding_transcript_exon_variant | 6/21 | ENSP00000510756.1 | |||||
AP2A2 | ENST00000693238.1 | n.676G>A | non_coding_transcript_exon_variant | 6/20 | ENSP00000510648.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152208Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
2
AN:
152208
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000403 AC: 1AN: 248276Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 134700
GnomAD3 exomes
AF:
AC:
1
AN:
248276
Hom.:
AF XY:
AC XY:
0
AN XY:
134700
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000684 AC: 10AN: 1461110Hom.: 0 Cov.: 30 AF XY: 0.00000826 AC XY: 6AN XY: 726794
GnomAD4 exome
AF:
AC:
10
AN:
1461110
Hom.:
Cov.:
30
AF XY:
AC XY:
6
AN XY:
726794
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152208Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74356
GnomAD4 genome
AF:
AC:
2
AN:
152208
Hom.:
Cov.:
33
AF XY:
AC XY:
1
AN XY:
74356
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
1
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 12, 2021 | The c.676G>A (p.V226M) alteration is located in exon 6 (coding exon 6) of the AP2A2 gene. This alteration results from a G to A substitution at nucleotide position 676, causing the valine (V) at amino acid position 226 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
.;.;T;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Pathogenic
D;.;D;D
M_CAP
Benign
D
MetaRNN
Uncertain
D;D;D;D
MetaSVM
Benign
T
MutationAssessor
Pathogenic
M;.;.;M
PrimateAI
Uncertain
T
PROVEAN
Uncertain
N;D;D;N
REVEL
Uncertain
Sift
Uncertain
D;D;D;T
Sift4G
Uncertain
D;D;D;D
Polyphen
D;.;.;D
Vest4
MutPred
Gain of catalytic residue at V226 (P = 0.0297);.;Gain of catalytic residue at V226 (P = 0.0297);Gain of catalytic residue at V226 (P = 0.0297);
MVP
MPC
1.6
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at